Hikma Pharmaceutical | HIK - Ebit

Stock Price
1,653.00
Daily Change
34.00 2.10%
Monthly
5.42%
Yearly
-28.01%
Q1 Forecast
1,600.34

Hikma Pharmaceutical reported $317M in EBIT for its fiscal semester ending in December of 2024.





Ebit Change Date
Almirall EUR 30.23M 12.8M Dec/2025
argenx SE USD 349.97M 61.94M Sep/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Autolus Therapeutics Ltd USD -82.61M 17.37M Jun/2025
Bayer EUR -399M 363M Sep/2025
Fresenius EUR 574M 14M Sep/2025
Galapagos EUR -41.67M 15.35M Sep/2025
Genmab DKK 432M 900.27M Jun/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Lonza CHF 673M 54M Jun/2025
Merck EUR 1.21B 180M Sep/2025
Orion EUR 328.1M 207.1M Dec/2025
Recordati EUR 278.23M 112.58M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 502M 168M Dec/2024